Company Filing History:
Years Active: 2014
Title: Anne Saaristo: Innovator in Lymphedema Treatment
Introduction
Anne Saaristo is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of medical science, particularly in the treatment of lymphedema. Her innovative approach combines lymph node transfer with growth factor therapy, showcasing her dedication to improving patient outcomes.
Latest Patents
Anne Saaristo holds a patent titled "Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery." This patent outlines materials and methods designed to enhance the survival of lymph nodes and their integration into a lymphatic network following transplantation. The invention addresses both the treatment and prevention of lymphedema, providing a method that includes transferring a lymph node or lymph node fragment in a mammalian subject. The administration of a composition containing Vascular Endothelial Growth Factor C (VEGF-C) or Vascular Endothelial Growth Factor D (VEGF-D) is also detailed, promoting the survival and integration of the lymph node at the site of transfer.
Career Highlights
Anne Saaristo has established herself as a leading figure in her field through her innovative research and development efforts. Her work has not only advanced scientific understanding but has also paved the way for new therapeutic options for patients suffering from lymphedema.
Collaborations
Anne collaborates with Kari Alitalo, a respected figure in the field. Their partnership exemplifies the importance of teamwork in advancing medical research and innovation.
Conclusion
Anne Saaristo's contributions to the treatment of lymphedema through her innovative patent highlight her role as a key inventor in the medical field. Her work continues to inspire advancements in patient care and therapeutic techniques.